<DOC>
	<DOCNO>NCT02181127</DOCNO>
	<brief_summary>This study test hypothesis wearable automate bionic pancreas system automatically deliver glucagon prevent treat hypoglycemia vs. usual care people type 1 diabetes &gt; 21 year old .</brief_summary>
	<brief_title>Closed-Loop Glucagon Administration For Hypoglycemia Treatment</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age 21 year old type 1 diabetes least one year . Otherwise healthy ( mild chronic disease asthma , hypertension , depression allow well control ) . Selfreported frequency document hypoglycemia ( BG &lt; 60 mg/dl ) least 2 time per week Partial hypoglycemic unawareness ( inconsistent symptom BG &lt; 50 mg/dl ) hypoglycemic unawareness ( minimal symptom BG &lt; 50 mg/dl ) Unable provide inform consent . Unable comply study procedure . Current participation another diabetesrelated clinical trial one primarily observational nature . Pregnancy ( positive urine HCG ) , breast feeding , plan become pregnant immediate future , sexually active without use contraception History cystic fibrosis , pancreatitis , pancreatic disease type 1 diabetes End stage renal disease dialysis ( hemodialysis peritoneal dialysis ) . Any known liver biliary disease include cirrhosis , alcoholic liver disease , nonalcoholic fatty liver disease , nonalcoholic steatohepatitis , form viral hepatitis . Congestive heart failure ( establish history CHF , paroxysmal nocturnal dyspnea , orthopnea ) . Acute illness exacerbation chronic illness time study . Seizure disorder history hypoglycemic seizure last 1 year History pheochromocytoma . Fractionated metanephrines test patient history increase risk catecholamine secrete tumor : Untreated inadequately treated mental illness ( indicator would include symptoms psychosis , hallucination , mania , psychiatric hospitalization last year ) . Current alcohol abuse ( intake average &gt; 3 drink daily last 30 day ) substance abuse ( use within last 6 month control substance without prescription ) . Electrically powered implant ( e.g . cochlear implant , neurostimulators ) might susceptible RF interference . History adverse reaction glucagon ( include allergy ) besides nausea vomiting . Unwilling unable completely avoid acetaminophen study period . Any factor , opinion principal investigator , would interfere safe completion study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>bionic pancreas</keyword>
	<keyword>artificial pancreas</keyword>
	<keyword>insulin</keyword>
	<keyword>glucagon</keyword>
	<keyword>continuous glucose monitoring ( CGM )</keyword>
	<keyword>outpatient</keyword>
	<keyword>insulin pump</keyword>
	<keyword>glucagon pump</keyword>
</DOC>